Here are relevant reports on : education-administration-market
-
US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2025
The global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Identity and Access Management (IAM) Market by Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type (Workforce, CIAM, B2B), Identity Type, Deployment Mode, Vertical - Global Forecast to 2030
The identity and access management (IAM) market is expected to grow from USD 25.96 billion in 2025 to USD 42.61 billion by 2030, at a compound annual growth rate (CAGR) of 10.4% during the forecast period. The Key Players Microsoft (US), Ping Identity (US), IBM (US), Okta (US), Oracle (US), SailPoint (US), Saviynt (US), CyberArk (US), Thales (France), Akamai Technologies (US), OpenText (Canada), Entrust (US), Duo Security (US), HID Global (US), Evidian (France), RSA Security (US), Avatier (US), ManageEngine (US), SecureAuth (US), EmpowerID (US), Simeio (US), One Identity (US), FusionAuth (US), Auth0 (US), IDnow (Germany), Zuora (US), Signzy (India), Civic Technologies (US), Trusona (US), Beyond Identity (US), Delinea (US), Optimal IdM (US), Netwrix (US), Aquera (US), Cerby (US), Traxion (Netherlands), Radiant Logic (US), Elimity (Belgium), Oleria (US), Veza (US), Bravura Security (Canada), Fischer Identity (US), Lumos (US), Omada (Denmark), OpenIAM (US), Pathlock (US), Tuebora (US), and Rippling (US)
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030
The global veterinary vaccines market, valued at US$10.94 billion in 2024, stood at US$11.63 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$16.15 billion by the end of the period. The continuous focus on developing novel and advanced vaccines, combined with the increasing application of these vaccines in emerging economies, is expected to drive market growth.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Device (Insulin, Syringe, Volumetric, Enteral, PCA Pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031
The Europe infusion pump market, valued at USD 4.78 billion in 2025, stood at USD 5.10 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a resilient CAGR of 4.8% from 2025 to 2030, culminating in a forecasted valuation of US$63.66 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
APAC Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The APAC injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Consumer Identity and Access Management (CIAM) Market by Solutions (Identity Administration, PII Management & Analytics, Access Management, Fraud Detection), Services, Authentication Type, and Vertical - Global Forecast to 2030
The global Consumer IAM market size is projected to grow from USD 14.12 billion in 2025 to USD 22.47 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 9.7 % during the forecast period. IBM (US), Okta (US), SAP (US), Microsoft (US), Ping Identity (US), Thales (France), Broadcom (US), AWS (US), Salesforce (US), OpenText (Canada), Akamai Technology (US), Deloitte (UK), HID Global (US), CyberArk (US), Nevis Security (Switzerland), Simeio Solutions (US), Ubisecure (Finland), OneLogin (US), SecureAuth (US), LoginRadius (Canada), IDology (US), Omada Identity (Denmark), WSO2 (US), WidasConcepts (Germany), FusionAuth (US), Transmit Security (Israel), IDnow (Germany), MiniOrange (US), Strivacity (US) are the key players and other players in the CIAM market.
- Published: October 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
